0001127602-21-010158.txt : 20210310 0001127602-21-010158.hdr.sgml : 20210310 20210310204640 ACCESSION NUMBER: 0001127602-21-010158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ACKERMANN CHRISTINA CENTRAL INDEX KEY: 0001681871 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 21731510 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-03-08 0000885590 Bausch Health Companies Inc. BHC 0001681871 ACKERMANN CHRISTINA 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 EVP AND GENERAL COUNSEL Common Shares, No Par Value 2021-03-08 4 M 0 8455 A 163534 D Common Shares, No Par Value 2021-03-08 4 A 0 25980 0 A 189514 D Common Shares, No Par Value 2021-03-10 4 F 0 21960 32.97 D 167554 D Restricted Share Units 2021-03-08 4 M 0 8455 D 2021-03-07 Common Stock 8455 0 D Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Each PSU converts into Common Shares on a one-for-one basis. This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 13,638 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. /s/ Kirsten O'Donnell, attorney-in-fact for Christina Ackermann 2021-03-10